Elevance Health (ELV) fundamentals: P/E, valuation, undervalued?
Elevance Health · Health Care · ref. ETF XLV · price $399.11
In short — Elevance Health trades at 17.8× earnings (P/E), 13.5× forward, with a net margin of 2.5 % and revenue growth of +1 %. Read: Average P/E (P/E 18 (near the ~20-25 average)).
Is Elevance Health stock cheap or undervalued? A good time to buy? Here are its fundamentals — P/E, PEG, margin and income statement — to judge its valuation.
📈 1-year price
$399.11+28.6% over range
Aug 28, 25low $280.74 · high $426.79Aug 27, 26
📏 Click 2 points (left → right) to measure the change · click again to clear.
SellBuy
Buy
72% recommend buying · 18 analysts
Valuation : Average P/E — P/E 18 (near the ~20-25 average)
Valuation
17.8
P/E (price/earnings)
13.5
Forward P/E
—
PEG
1.9
Price/book (P/B)
$86.6B
Market cap
22.43
EPS
Profitability & growth
2.5 %
Net margin
+1 %
Revenue growth
-13 %
Earnings growth
$31.0B
Total debt
Elevance Health income statement
| Fiscal year | Revenue | Net income | Margin |
|---|---|---|---|
| 2022 | $155.7B | $6.0B | 3.9 % |
| 2023 | $170.2B | $6.0B | 3.5 % |
| 2024 | $175.2B | $6.0B | 3.4 % |
| 2025 | $197.6B | $5.7B | 2.9 % |
⚠️ Indicative financial data (Yahoo Finance), not investment advice. Amounts in $.
Frequently asked questions
What is Elevance Health's P/E and is the stock undervalued? What's a good P/E?
Elevance Health's P/E is 17.8 (forward 13.5). Below ~15 = fairly cheap, above ~30 = expensive. Our valuation verdict: "Average P/E".
Is Elevance Health profitable?
Elevance Health has a net margin of 2.5 % (EPS 22.43). The company is profitable.
Is ELV stock expensive?
Our read: "Average P/E" — P/E 18 (near the ~20-25 average). Cross-check with growth and sector.
💬 A question about Elevance Health? The JPI assistant answers using our backtest data.